Caitlin Sheetz, Pete Kardel, Irene Varghese, and David Liu from our Strategic Analytics Value and Economics (SAVEs) team will share information on SGLT-2 Inhibitors Prescription Disparities and Affordability Among Medicare Patients with Diabetes, Mortality in CAR-T Medicare and Medicaid Patients, and the Inflation Reduction Act (IRA) Impact on Medicare Part D Beneficiaries Out-of-Pocket (OOP) Spending on Insulin.
You can view all three posters below.
Evaluating Six Month Mortality in Medicare and Medicaid CAR-T Patients